Arginase 1 Is a Key Driver of Immune Suppression in Pancreatic Cancer

By
Bob
-
0
145
Researchers used a genetic and a pharmacologic approach to target Arginase 1 (Arg1) in pancreatic cancer to investigate Arg1’s metabolic function.
[eLife]
Abstract